Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had […]
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had […]
TORONTO, July 17, 2024 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today that it has […]
First aircraft (Lilium Jet MSN 1) to be used exclusively for ground testing starting in a few weeks Second aircraft […]
Increases business footprint to nearly 20,000 retail stores across Asia Pacific New services include smart retail solutions to enhance store […]
FREMONT, Calif., July 17, 2024 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced […]
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 17, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a leader in digital […]
COLUMBUS, Ohio, July 17, 2024 (GLOBE NEWSWIRE) — Bread Financial, a tech-forward financial services company that provides simple, personalized payment, […]
TEL AVIV, Israel, July 17, 2024 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a leading developer […]
MELBOURNE, Australia and PRINCETON, N.J., July 17, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage […]
SciSparc will receive additional payments and execution fees if certain milestones are met TEL AVIV, Israel, July 17, 2024 (GLOBE […]